Dyspnea perception and reversibility of methacholine-induced unlimited airway narrowing in asthmatics

Journal of Asthma

Volumn 43, Issue 6, 2006, Pages 463-467

  Malakauskas, Kestutis ^a   Sitkauskiene, Brigita ^a   Stravinskaite, Kristina ^a   Sakalauskas, Raimundas ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Asthma; Bronchial hyperresponsiveness; Bronchial reversibility; Dyspnea; Unlimited airway narrowing

Indexed keywords

METHACHOLINE; SALBUTAMOL;

ADULT; AIRWAY CONSTRICTION; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PERCEPTION; PROVOCATION TEST;

ADOLESCENT; ADULT; ALBUTEROL; ASTHMA; BRONCHI; BRONCHOCONSTRICTION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; PERCEPTION;

EID: 33748465734     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900600758366     Document Type: Article

References (32)

1. NHLBI/WHO Workshop Report. Global strategy for asthma management and prevention: Global Initiative for Asthma (GINA). National Institutes of Health, 02-3659, 2002.
2. Lötvall J, Inman M, O'Byrne P. Measurement of airway hyperresponsiveness: New considerations. Thorax 1998; 53:419-424.
3. Sterk PJ, Bel EH. Bronchial hyperresponsiveness: The need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 1989; 2:267-274.
4. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143:138-143.
5. Molfino NA, Nannini LJ, Martelli AN, Slutsky AS. Respiratory arrest in near-fatal asthma. N Engl J Med 1991; 324:285-288.
6. Kikuchi Y, Okabe S, Tamura G, Hida W, Homma M, Shirato K, Takishima T. Chemosensitiviy and perception of dyspnea in patients with a history of near fatal asthma. N Engl J Med 1994; 330:1329-1334.
7. Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near-fatal asthma and fatal asthma in relation to the perception of dyspnea. Chest 2002; 121:329-333.
8. Barreiro E, Gea J, Sanjuas C, Marcos R, Broquetas J, Milic-Emili J. Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma. Eur Respir J 2004; 24:219-225.
9. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics, 2002. J Allergy Clin Immunol 2002; 110 (suppl 5):S141-219.
10. Brusasco V, Crimi E. Methacholine provocation test for diagnosis of allergic respiratory diseases. Allergy 2001; 56:1114-1120.
11. Quanjer PhH, Tammeling GF, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Report working party. Standardization of lung function tests. European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 6(suppl 16):5-40.
12. Klein G. Scientific "Bronchial provocation tests" Study group. Recommendations for implementing bronchial provocation tests with pharmacological substances. Med Klin 1997; 92:458-463.
13. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14:377-381.
14. 2-agonists, improve the perception of bronchoconstriction in asthma. Am J Respir Crit Care Med 2001; 164:764-769.
15. Boulet LP, Cournoyer I, Deschesnes F, Leblanc P, Nouwen A. Perception of airflow obstruction and associated breathlessness in normal and asthmatic subjects: Correlation with anxiety and bronchodilator needs. Thorax 1994; 49:965-970.
16. Banzett RB, Dempsey JA, O'Donnell DE, Wamboldt MZ. Symptom perception and respiratory sensation in asthma. Am J Respir Crit Care Med 2000; 162:1178-1182.
17. Koh YI, Choi IS, Lim H. Airway responsiveness as a direct factor contributing to the dyspnoea perception in asthma. Respir Med 2001; 95:464-470.
18. Roisman GL, Peiffer C, Lacronique JG, Le Cae A, Dusser DJ. Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. J Clin Invest 1995; 96:12-21.
19. Ottanelli R, Rosi E, Romagnoli I, Grazzini M, Stendardi L, Duranti R, Scano G. Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma? Chest 2001; 120:770-777.
20. Lougheed MD, Lam M, Forkert L, Webb KA, O'Donnell DE. Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms. Am Rev Respir Dis 1993;148 (Pt 1):1452-1459.
21. Bijl-Hofland ID, Folgering HThM, van den Hoogen H, Cloosterman SGM, van Weel C, Donkers JM, van Schayck CP. Perception of bronchoconstriction in asthma patients measured during histamine challenge test. Eur Respir J 1999; 14:1049-1054.
22. Salome CM, Reddel HK, Ware SI, Roberts AM, Jenkins CR, Marks GB, Woolcock AJ. Effect of budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med 2002; 165:15-21.
23. Booms P, Cheung D, Timmers MC, Zwinderman AH, Sterk PJ. Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma. J Allergy Clin Immunol 1997; 99:330-337.
24. Buck H, Parry-Billings M. Discriminating measures of bronchodilator drug efficacy and potency. Br J Clin Pharmacol 2001; 52:245-253.
25. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164:744-748.
26. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152:838-860.
27. Strauss L, Hejaj R, Galan G, Dixon L, McFadden ER. Observations on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 1997; 155:454-458.
28. Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest 1998; 113:593-598.
29. Persson CGA. Plasma exudation in the airways: Mechanism and function. Eur Respir J 1991; 4:1268-1274.
30. Polosa R, Prosperini G, Magri S, Ciamarra I, Pagano C, Paolino G, Santonocito G, Crimi N. Bronchodilator response to salbutamol after spontaneous recovery from nonspecific bronchial provocation tests in asthma. Eur Respir J 1998; 11:1086-1090.
31. 2 agonists. Thorax 2001; 56:529-535.
32. Weiner P, Beckerman M, Berar-Yanay N, Magadle R. The perception of dyspnea after bronchoconstriction and bronchodilation in patients with asthma. Respir Med 2003; 97:1120-1125.